Back to results
US 2003/0077271 A1Published application
Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disorders
OwnerChristian Kannemeier, Juergen Roemisch +2inventors
InventorsChristian Kannemeier, Juergen Roemisch, Klaus T. Preissner, Sandip Kanse
Life of this patent
Estimating the term…
Abstract
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy, rheumatoid arthritis, psoriasis, endometriosis, bronchitis (especially chronic) or chronic inflammations in the gastrointestinal tract.
Claims4
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses.
Dependencies are inferred from the claim text.